Cagrilintide is a next-generation amylin analog widely recognized for its role in appetite management and satiety support research. Designed to support healthy eating behaviors and weight-management strategies, Cagrilintide has become a popular choice among researchers and wellness professionals focused on body composition and metabolic wellness. Frequently explored alongside GLP-1-based approaches, Cagrilintide continues to gain attention as one of the most promising peptides in the weight-management space.